Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Mar 10, 2014, after the close
10-K filed Mar 10, 2014, 69 days after period end · 0001144204-14-014279
| Metric | Q4 2013 | Q4 2012 | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Revenue | $2.50K | $2.50K | — | — |
| Net Income | -$3.30M | -$2.71M | -$2.56M |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| — |
| EPS Diluted | -$0.04 | -$0.04 | — | — |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
